Ginkgo Bioworks Holdings, Inc. (DNA)

NYSE

$12.90

$+0.11

(+0.86%)

Pre-Market

Ginkgo Bioworks Holdings, Inc. (DNA) Live Price Chart

Last updated: ⁦2026-10-01 10:18:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Ginkgo Bioworks Holdings, Inc. (DNA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NYSE. The stock is currently priced at $12.90, with a market capitalisation of $805.39M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $5.37 to $17.58. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$805.39M
Open	$12.84
Day's High	$39,999.60
Day's Low	$0.40
Previous Close	$12.83
Volume	14.03K
Average Volume	1.35M
P/E Ratio	--
52-Week High	$17.58
52-Week Low	$5.37
Dividend Yield	--
Earnings Date	--

Ginkgo Bioworks Holdings, Inc. (DNA) Pre-Market Stock Price

Ginkgo Bioworks Holdings, Inc. (DNA) is trading at $12.90 in pre-market trading as of 2026-10-01 10:12:00, up 0.51% ($0.06) from the previous close of $12.83

Pre-market trading shows how investors are pricing DNA before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Ginkgo Bioworks Holdings, Inc. (DNA) 7-Day Stock Price Change

Over the past seven days, Ginkgo Bioworks Holdings, Inc. (DNA) moved from $9.37 to $12.90, representing a gain of 37.62% ($3.53).

The stock traded between $7.80 and $13.42 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 3.29 million shares, up versus the previous seven-day period, indicating higher trading activity.

DNA 52-Week Price Position

Position in Range: 61.6%

52W Low$5.37

52W High$17.58

DNA is currently trading at $12.90, placing it 61.6% of the way from its 52-week low of $5.37 to its 52-week high of $17.58. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Ginkgo Bioworks Holdings, Inc. (DNA)?

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Ginkgo Bioworks Holdings, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	485
Exchange	NYSE
Company Website	https://www.ginkgobioworks.com

How to Buy Ginkgo Bioworks Holdings, Inc. (DNA) Stock on MEXC

Eligible investors can buy real shares of Ginkgo Bioworks Holdings, Inc. (DNA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for DNA and Place Your Order

Open the RealStocks trading page and search for DNA. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Ginkgo Bioworks Holdings, Inc. (DNA) stock price today?

Ginkgo Bioworks Holdings, Inc. (DNA) is currently trading at $ 12.90, up 0.51% ($0.06) from the previous close of $ 12.83. Intraday prices update in real time during regular trading hours.

2.Is DNA stock going up or down today?

As of 2026-10-01 10:12:00, DNA is trading at $ 12.90, up 0.51% ($0.06) from its previous close of $ 12.83. The stock has traded between $ 0.40 and $ 39,999.60 during today’s regular session. Past price movements do not guarantee future results.

3.What is DNA pre-market price?

As of 2026-10-01 10:12:00, DNA is trading at $ 12.90 in pre-market trading, up 0.51% ($0.06) from the previous close of $ 12.83. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is DNA after-hours price?

As of 2026-10-01 10:12:00, DNA is trading at $ 12.80 in after-hours trading, down 0.27% ($0.04) from the regular-session close of $ 12.83. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is DNA stock trading now?

DNA trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does DNA sit relative to its 52-week high and low?

Over the past 52 weeks, DNA has traded between a low of $ 5.37 and a high of $ 17.58. At $ 12.90, the stock is positioned 61.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Ginkgo Bioworks Holdings, Inc. in?

Ginkgo Bioworks Holdings, Inc. (DNA) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Ginkgo Bioworks Holdings, Inc.'s market capitalisation and where is it listed?

Ginkgo Bioworks Holdings, Inc. is listed on the NYSE exchange with a market capitalisation of $ 805.39M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is DNA valued in terms of P/E ratio and EPS?

DNA trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -4.32. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Ginkgo Bioworks Holdings, Inc. pay a dividend?

Ginkgo Bioworks Holdings, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.